MGVS clinical research program is focused on areas of unmet needs in cardiovascular disease. MGVS is committed to transparency in medical research. We have registered our active company-sponsored clinical trials on the National Institutes of Health clinical trial database. www.clinicaltrials.gov

MultiGeneAngio
We have completed enrollment and treatment of 12 patients in the first phase I/IIa study of MultiGeneAngio for severe claudication in two leading medical centers in the USA: the University of Michigan and  the University of Pennsylvania. Preliminary assessment demonstrated promising safety and clinical results. A second clinical study, for chronic critical limb ischemia (a more advanced stage of peripheral arterial disease) is currently being conducted in 7 leading medical centers in Israel:

Barzilai Medical Center, Ashkelon
PI: Prof. Boris Yoffe, M.D.
Tel: 972-8-6745656
Email: sarel@barzi.health.gov.il

Bnei-Zion Medical Center, Haifa
PI: Dr. Simone Fajer, M.D.
Tel: 972-4-8359137
Email: simone.fajer@b-zion.org.il

Chaim Sheba Medical Center , Tel-Hashomer
PI: Dr. Moshe Halak, M.D.
Tel: 972-3-5302712
Email: Moshe.Halak@sheba.health.gov.il

Hadassah University Hospital, Ein Kerem, Jerusalem
PI: Prof. Allan Bloom, M.D.
Tel: 972-2-6776502
Email: allan@hadassah.org.il

Kaplan Medical Center, Rehovot
PI: Dr. Eran Weinmann, M.D.
Tel: 972-8-9441761
Email: eew@clalit.org.il

Rambam Medical Center, Haifa
PI: Prof. Aaron Hoffman, M.D.
Tel: 972-4-8543119, 972-4-8541299
Email: ahofman@rambam.health.gov.il

Shaar'e-Zedek Medical Center, Jerusalem
PI: Dr. Ilya Goldin, M.D.
Tel: 972-2-6666310
Email: migoldin@gmail.com